These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 24476803)

  • 41. [Spectrum of cardiovascular disease in HIV-infected patients].
    Lozano F
    Enferm Infecc Microbiol Clin; 2009 Sep; 27 Suppl 1():3-9. PubMed ID: 20172409
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction.
    García-Cruz E; Leibar-Tamayo A; Romero J; Piqueras M; Luque P; Cardeñosa O; Alcaraz A
    J Sex Med; 2013 Oct; 10(10):2529-38. PubMed ID: 23898860
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peripheral atherosclerosis and serum lipoprotein(a) in diabetes.
    Wollesen F; Dahlén G; Berglund L; Berne C
    Diabetes Care; 1999 Jan; 22(1):93-8. PubMed ID: 10333909
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of and risk factors for peripheral arterial disease among Chinese hypertensive patients with and without known cardiovascular disease.
    Zheng L; Yu J; Li J; Li X; Luo Y; Hasimu B; Sun Z; Sun Y; Hu D
    Acta Cardiol; 2008 Dec; 63(6):693-9. PubMed ID: 19157163
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Assessment of endothelial function in autoimmune diseases].
    Benhamou Y; Bellien J; Armengol G; Gomez E; Richard V; Lévesque H; Joannidès R
    Rev Med Interne; 2014 Aug; 35(8):512-23. PubMed ID: 24412013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The relation between peripheral arterial occlusive disease and cardiovascular diseases in elderly population: a cross-section study in Wanshoulu area, Beijing].
    Li XY; Wang J; He Y; Fan L
    Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(21):1847-51. PubMed ID: 14642063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Telomeres and cardiovascular disease: new perspectives in hypertension.
    Nilsson PM
    J Hum Hypertens; 2011 Dec; 25(12):703-4. PubMed ID: 21776017
    [No Abstract]   [Full Text] [Related]  

  • 48. Peripheral arterial disease: implications beyond the peripheral circulation.
    Paraskevas KI; Mukherjee D; Whayne TF
    Angiology; 2013 Nov; 64(8):569-71. PubMed ID: 23221278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of body mass index, metabolic syndrome, and leukocyte count.
    Desai MY; Dalal D; Santos RD; Carvalho JA; Nasir K; Blumenthal RS
    Am J Cardiol; 2006 Mar; 97(6):835-8. PubMed ID: 16516585
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Cardiovascular risk factors in peripheral arterial disease. A study of 403 cases].
    Marín R; Fernández-Vega F; Escalada P; Estevan JM; Barreiro A; Alvarez J
    Rev Clin Esp; 1993 Nov; 193(7):357-62. PubMed ID: 8290754
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Importance of determination of azurophilic granularity in the lymphocytes].
    Miansarian IT
    Zh Eksp Klin Med; 1977; 17(2):106-7. PubMed ID: 888623
    [No Abstract]   [Full Text] [Related]  

  • 52. Cardiovascular risk factors and systemic endothelial function in patients with cirrhosis.
    Berzigotti A; Erice E; Gilabert R; Reverter E; Abraldes JG; García-Pagan JC; Bosch J
    Am J Gastroenterol; 2013 Jan; 108(1):75-82. PubMed ID: 23147518
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heparin cofactor II is an independent protective factor against peripheral arterial disease in elderly subjects with cardiovascular risk factors.
    Aihara K; Azuma H; Akaike M; Kurobe H; Takamori N; Ikeda Y; Sumitomo Y; Yoshida S; Yagi S; Iwase T; Ishikawa K; Sata M; Kitagawa T; Matsumoto T
    J Atheroscler Thromb; 2009 Apr; 16(2):127-34. PubMed ID: 19403987
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The importance of associated extra-renal vascular disease on the outcome of patients with atherosclerotic renovascular disease.
    Shurrab AE; MacDowall P; Wright J; Mamtora H; Kalra PA
    Nephron Clin Pract; 2003; 93(2):C51-7. PubMed ID: 12616031
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Vasculitis].
    VILOTIJEVIC R; STRINIC F; MASULOVIC M; MILOVIC K
    Presse Med (1893); 1959 May; 67(22):898. PubMed ID: 13658027
    [No Abstract]   [Full Text] [Related]  

  • 56. Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk.
    Ramos R; Quesada M; Solanas P; Subirana I; Sala J; Vila J; Masiá R; Cerezo C; Elosua R; Grau M; Cordón F; Juvinyà D; Fitó M; Isabel Covas M; Clarà A; Angel Muñoz M; Marrugat J;
    Eur J Vasc Endovasc Surg; 2009 Sep; 38(3):305-11. PubMed ID: 19515589
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of comorbidity burden on the cardiovascular risk in the Peripheral Arteriopathy and Cardiovascular Events study.
    Brevetti G; Giugliano G; Oliva G; Lanero S; De Maio JI; Chiariello M
    QJM; 2008 Jul; 101(7):575-82. PubMed ID: 18463142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implications.
    Cibor D; Domagala-Rodacka R; Rodacki T; Jurczyszyn A; Mach T; Owczarek D
    World J Gastroenterol; 2016 Jan; 22(3):1067-77. PubMed ID: 26811647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Leukocyte count in peripheral arterial disease: A simple, reliable, inexpensive approach to cardiovascular risk prediction.
    Giugliano G; Brevetti G; Lanero S; Schiano V; Laurenzano E; Chiariello M
    Atherosclerosis; 2010 May; 210(1):288-93. PubMed ID: 19963213
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Erectile vascular dysfunction and analysis of the risk factors related to it: clinical experience.
    La Vignera S; Calogero AE; Cannizzaro MA; Vicari E
    Minerva Endocrinol; 2007 Mar; 32(1):17-21. PubMed ID: 17353863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.